Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 USD | 0.00% | 0.00% | +45.45% |
Apr. 19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
Business Summary
Number of employees: 9
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cell-based Technologies
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +442.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +442.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Peter Clausen
COO | Chief Operating Officer | 58 | 08-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
C. Eric Winzer
BRD | Director/Board Member | 67 | 09-01-29 |
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Paul D. Mintz
BRD | Director/Board Member | 75 | 17-04-06 |
Scott Pittman
BRD | Director/Board Member | 65 | 16-05-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,241,516 | 17,391,995 ( 39.31 %) | 0 | 39.31 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+45.45% | 35.39M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- AURX Stock
- Company Nuo Therapeutics, Inc.